ReviewWorld journal of hepatology2024

Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges.

Chencheng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.